The composition and form of issue:
1 vial 2 ml injection solution contains etamzilata 0.25 g pack of 10
Increases the formation in the walls of capillaries mucopolysaccharides. Activates the formation of thromboplastin, and stimulates the formation III of the coagulation factor.
Normalizes capillary permeability in pathological processes, improves microcirculation, increases the adhesion of platelets, it has a hemostatic effect. At/in the introduction hemostatic effect develops in 5-15 minutes, the maximum effect — in 1-2 hours, lasts 4-6 hours or more. When the/m imposing effect is somewhat slower.
Bleeding (intestinal, uterine and operational interventions) in ENT, ophthalmic, dental, urological, surgical and gynecological practice, capillary bleeding, trauma, bleeding diathesis, diabetic angiopathy, polimenorea.
Hemorrhage on a background of anticoagulants, thrombosis, and embolism ( incl. history).
Application of pregnancy and breast-feeding:
To apply caution in the first trimester of pregnancy.
Headache, dizziness, flushing of the face, decreased blood pressure, paresthesia of the lower extremities.
Method of application and dose:
In/in, in/m for 1 h before surgery, for maintenance, 0.25–0.5 g (2-4 ml 12.5% solution). If risk of postoperative bleeding 0.5–0.75 g (4-6 oz) per day. If necessary, during operation/injected 0.25–0.5 g (2-4 ml). For medicinal purposes — 0,25–0,5 g (2-4 ml) overnight, and then 0.25 g every 4-6 h. you Can enter in/to drip, adding to the usual solutions for infusion. When metro – and menorrhagia — 0.25 g every 6 hours for 5-10 days, then 0.25 g 2 times a day during hemorrhage. Haemorrhagic diathesis and diabetic microvascular complications — 0.25–0.5 g 1-2 times a day.
Should not be mixed in the same syringe with other drugs.
|The purpose of the medication||Coagulants, homeostatics|